nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Answer to “REPLY to Association between Plasmatic Oxidative Stress and Thrombosis in Primary Antiphospholipid Syndrome”
|
Vaz, Camila de O. |
|
|
54 |
1 |
p. 191-192 |
artikel |
2 |
Arterial and venous involvement in Behçet’s syndrome: a narrative review
|
Toledo-Samaniego, Neera |
|
|
54 |
1 |
p. 162-171 |
artikel |
3 |
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention
|
Viscusi, Michele Mattia |
|
|
54 |
1 |
p. 15-19 |
artikel |
4 |
Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage
|
Pasciolla, Stacy |
|
|
54 |
1 |
p. 74-81 |
artikel |
5 |
Confirmation of the utility of the Wells’ Score for pulmonary embolism in patients with sickle cell disease
|
May, Jori E. |
|
|
54 |
1 |
p. 193-196 |
artikel |
6 |
Contact system activation in disseminated intravascular coagulation: activities of prekallikrein and high-molecular-weight kininogen are significant risk factors
|
Park, Sooyong |
|
|
54 |
1 |
p. 11-14 |
artikel |
7 |
Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome
|
Williams, Briana |
|
|
54 |
1 |
p. 67-73 |
artikel |
8 |
Dual antiplatelet therapy in the contemporary drug-eluting stents era: from vulnerable stents to vulnerable patients
|
Benenati, Stefano |
|
|
54 |
1 |
p. 153-155 |
artikel |
9 |
Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases
|
Lip, Gregory Y. H. |
|
|
54 |
1 |
p. 33-46 |
artikel |
10 |
Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study
|
Jiang, Shaojun |
|
|
54 |
1 |
p. 20-28 |
artikel |
11 |
Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension
|
Yang, Lifan |
|
|
54 |
1 |
p. 123-131 |
artikel |
12 |
Global coagulation assays in hypercoagulable states
|
Lim, Hui Yin |
|
|
54 |
1 |
p. 132-144 |
artikel |
13 |
Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis
|
Meloni, Bruno P. |
|
|
54 |
1 |
p. 172-182 |
artikel |
14 |
Impact of thrombus burden on long-term clinical outcomes in patients with either anterior or non-anterior ST-segment elevation myocardial infarction
|
Scarparo, Paola |
|
|
54 |
1 |
p. 47-57 |
artikel |
15 |
Incremental cost of venous thromboembolism in trauma patients with contraindications to prophylactic anticoagulation: a prospective economic study
|
Ho, Kwok M. |
|
|
54 |
1 |
p. 115-122 |
artikel |
16 |
Inpatient Management of Pulmonary Embolism: Clinical Characteristics and Mortality in a High-Volume Tertiary Care Center
|
Mudrakola, Harsha V. |
|
|
54 |
1 |
p. 145-152 |
artikel |
17 |
“Lockdown-thrombosis”—an unexpected problem of the COVID-19 pandemic?
|
Er, Chaozer |
|
|
54 |
1 |
p. 29-32 |
artikel |
18 |
Management of bone marrow biopsy related bleeding risks: a retrospective observational study
|
Grange, Lucile |
|
|
54 |
1 |
p. 109-114 |
artikel |
19 |
Nitric oxide acute kidney injury (NO-AKI) pilot trial
|
Lahoud, Rony N. |
|
|
54 |
1 |
p. 7-10 |
artikel |
20 |
Prevalence of recommended anticoagulation by guidelines preadmission and its impact on the incidence of acute myocardial infarction (AMI) and in-hospital outcomes after AMI in atrial fibrillation patients
|
Bai, Ying |
|
|
54 |
1 |
p. 91-96 |
artikel |
21 |
Prognostic impact of acute kidney injury in patients with acute pulmonary embolism data from the RIETE registry
|
Murgier, Martin |
|
|
54 |
1 |
p. 58-66 |
artikel |
22 |
Recurrent hematuria and painful necrotic purpura induced by acquired Protein S deficiency associated with monoclonal immunoglobulin
|
Tang, Wenjiao |
|
|
54 |
1 |
p. 156-161 |
artikel |
23 |
Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial
|
Ding, Wern Yew |
|
|
54 |
1 |
p. 1-6 |
artikel |
24 |
Single versus multiple and incidental versus symptomatic subsegmental pulmonary embolism: clinical characteristics and outcome
|
Hirao-Try, Yumiko |
|
|
54 |
1 |
p. 82-90 |
artikel |
25 |
The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis
|
Goh, Claire X. Y. |
|
|
54 |
1 |
p. 183-190 |
artikel |
26 |
Tissue factor: a neglected role in cancer biology
|
Li, Haiyuan |
|
|
54 |
1 |
p. 97-108 |
artikel |